Multi-Cancer Early Detection Test
Multi-Cancer Early Detection Test is a medical device with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
PATHFINDER 2: A Multi-Cancer Early Detection Study
A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy
PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection
The Unintrusive Detection of EaRly-stage Cancers
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
Clinical Trials (9)
PATHFINDER 2: A Multi-Cancer Early Detection Study
A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy
PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection
The Unintrusive Detection of EaRly-stage Cancers
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I
Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT
Pan-canceR Early DetectIon projeCT (PREDICT)
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9